48 / 164
178
11. Acosta A, Maíz A, Leighton F, Pollak F, Castilo O. Determinación
del índice de resistencia insulínica mediante HOMA en una
población de la RM de Chile. Rev Med Chile 2002; 130:1227-
1231.
12. Arancibia C, Galgani J, Morales M, Santos J, Valderas JP, Pollak
F. Evaluación de la insulinemia post carga oral de glucosa
como método diagnóstico de Resistencia a la Insulina. Rev.
Med. Chile, 2014,142 (9):1106-1112.
13. Manley SE, Stratton IM, Clark PM, Luzio SD. Comparison of 11
human insulin assays: implications for clinical investigation
and research. Clin Chem. 2007; 53(5): 922-32.
14. Finnish Diabetes Prevention Study Group. Prevention of Type 2
Diabetes Mellitus by Changes in Lifestyle among Subjects with
Impaired Glucose Tolerance. N Engl J Med 2001; 344:1343-
1350.
15. Diabetes Prevention Program Research Group. Reduction in
the Incidence of Type 2 Diabetes with Lifestyle Intervention or
Metformin. N Engl J Med 2002; 346:393-403.
16. Vessby B, Uusitupa M, Hermansen K, et al; KANWU Study.
Substituting dietary saturated for monounsaturated fat
impairs insulin sensitivity in healthy men and women: The
KANWU Study. Diabetologia. 2001 Mar;44(3):312-9.
17. Arteaga A. El Índice glicémico, una controversia actual. Nutr.
Hosp. (2006) 21 (Supl. 2) 55-60.
18. PollockNK, Bundy V, KantoW, et al. Greater fructose consumption
is associated with cardiometabolic risk markers and visceral
adiposity in adolescents. J Nutr. 2012 Feb;142(2):251-7.
19. Salas-Salvadó J, Bulló M, Babio N, et al ; PREDIMED Study
Investigators. Reduction in the incidence of type 2 diabetes
with the Mediterranean diet: results of the PREDIMED-Reus
nutrition intervention randomized trial. Diabetes Care. 2011
Jan;34(1):14-9.
20. PREDIMED Study Investigators. Primary Prevention of
Cardiovascular Disease with a Mediterranean Diet. N Engl J
Med 2013; 368:1279-1290.
21. Li G, Zhang P, Wang J, Gregg EW, et al. The long-term effect of
lifestyle interventions to prevent diabetes in the China Da Qing
Diabetes Prevention Study: a 20-year follow-up study. Lancet
2008; 371(9626): 1783-1789.
22. Alvarez C., Ramírez-Campillo R., Flores M., et al. Respuestas
metabólicas inducidas por ejercicio físico de alta intensidad
en mujeres sedentarias con glicemia basal alterada e
hipercolesterolemia. Rev Med Chile 2013; 141: 1293-1299.
23. ACT NOW Study. Pioglitazone for Diabetes Prevention in
Impaired Glucose Tolerance. N Engl J Med 2011; 364:1104-
1115.
24. Boettcher E, Csako G, Pucino F, Wesley R, Loomba R. Meta-
analysis: pioglitazone improves liver histology and fibrosis
in patients with non-alcoholic steatohepatitis. Aliment
Pharmacol Ther. 2012 35:66-75.
25. Nathan DM, Davidson MB, DeFronzo RA, et al; American
Diabetes Association. Impaired fasting glucose and impaired
glucose tolerance: implications for care. Diabetes Care. 2007
Mar;30(3):753-9.
26. Vanky E, Stridsklev S, Heimstad R, et al. Metformin versus
placebo from first trimester to delivery in polycystic ovary
syndrome: a randomized, controlled multicenter study. JCEM
2010;95:E448-455.
27. Palomba S, Falbo A, Orio F Jr, Zullo F. Effect of preconceptional
metformin on abortion risk in polycystic ovary syndrome: a
systematic review and meta-analysis of randomized controlled
trials. Fertil Steril 2009;92:1646-1658.
28. Tso LO, Costello MF, Albuquerque LE, Andriolo RB, Macedo CR.
Metformin treatment before and during IVF or ICSI in women
with polycystic ovary syndrome. Cochrane Database Syst Rev.
2014 Nov 18;11:CD006105.
[REV. MED. CLIN. CONDES - 2016; 27(2) 171-178]